Website
N/ATelephone
61.2.9209.4037
Address
4 Cornwallis Street National Innovation Centre Eveleigh, New South Wales (NSW) 2015
Description
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.97 - 7.45
Trade Value (12mth)
AU$963,533.00
1 week
-4.98%
1 month
18.45%
YTD
226.6%
1 year
556.32%
All time high
7.45
EPS 3 yr Growth
288.20%
EBITDA Margin
N/A
Operating Cashflow
-$43m
Free Cash Flow Return
-40.10%
ROIC
-39.30%
Interest Coverage
N/A
Quick Ratio
19.00
Shares on Issue (Fully Dilluted)
281m
HALO Sector
Healthcare
Next Company Report Date
20-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.05
Date | Announcements |
---|---|
04 September 24 |
Application for quotation of securities - CU6
×
Application for quotation of securities - CU6 |
04 September 24 |
Cleansing Notice
×
Cleansing Notice |
29 August 24 |
Application for quotation of securities - CU6
×
Application for quotation of securities - CU6 |
29 August 24 |
Cleansing Notice
×
Cleansing Notice |
26 August 24 |
Changes to Board of Directors and Management Team
×
Changes to Board of Directors and Management Team |
26 August 24 |
Final Director's Interest Notice - Rob Thomas
×
Final Director's Interest Notice - Rob Thomas |
23 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
22 August 24 |
FDA Fast Track Designation 64CU-SAR-bisPSMA
×
FDA Fast Track Designation 64CU-SAR-bisPSMA |
16 August 24 |
Notification regarding unquoted securities - CU6
×
Notification regarding unquoted securities - CU6 |
15 August 24 |
Application for quotation of securities - CU6
×
Application for quotation of securities - CU6 |
15 August 24 |
Cleansing Notice
×
Cleansing Notice |
12 August 24 |
Change of Director's Interest Notice - Biggin
×
Change of Director's Interest Notice - Biggin |
09 August 24 |
Application for quotation of securities - CU6
×
Application for quotation of securities - CU6 |
09 August 24 |
Cleansing Notice
×
Cleansing Notice |
05 August 24 |
Change of Director's Interest Notice - Biggin
×
Change of Director's Interest Notice - Biggin |
02 August 24 |
Change of Director's Interest Notice - Taylor
×
Change of Director's Interest Notice - Taylor |
02 August 24 |
Application for quotation of securities - CU6
×
Application for quotation of securities - CU6 |
02 August 24 |
Cleansing Notice
×
Cleansing Notice |
01 August 24 |
Application for quotation of securities - CU6
×
Application for quotation of securities - CU6 |
01 August 24 |
Cleansing Notice
×
Cleansing Notice |
31 July 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
16 July 24 |
Supply agreement for Ac-225 with TerraPower Isotopes
×
Supply agreement for Ac-225 with TerraPower Isotopes |
24 June 24 |
Clarity Receives $10 million R&D Tax Incentive
×
Clarity Receives $10 million R&D Tax Incentive |
20 June 24 |
Application for quotation of securities - CU6
×
Application for quotation of securities - CU6 |
20 June 24 |
Cleansing Notice
×
Cleansing Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.